Organisation paid for research Program year 2025 Source: CMS Open Payments

The Endocrine Center

Neither a doctor nor a teaching hospital

Research payments

$249,418

803 payments

Through program year 2025, The Endocrine Center is reported as receiving $249,418 in research payments, across 803 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $27,808 3
2024 Research $81,248 44
2023 Research $132,396 441
2022 Research $1,775 184
2021 Research $5,854 128
2019 Research $338 3

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $249,080 800 payments
  2. Pfizer Inc. $338 3 payments
Studies the money was for Research payments · program years 2019–2025
  1. Nn9536-7545 $243,227 672 payments
  2. Nn1535-4593 $4,686 80 payments
  3. Ex6018-4758 $1,167 48 payments
  4. Phase 2A Hepatic Impairment $178 2 payments
  5. A Phase 3 Randomized Doubleblind Placebocontrolled 26Week Multicenter Study With A 78Week Extension to Evaluate the Efficacy and Safety of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformin Mo $160 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record